Differential expression of interleukin-1/Toll-like receptor signaling regulators in microscopic and ulcerative colitis

World Journal of Gastroenterology

Volumn 20, Issue 34, 2014, Pages 12249-12259

  Günaltay, Sezin ^a   Nyhlin, Nils ^b   Kumawat, Ashok Kumar ^a   Tysk, Curt ^b   Bohr, Johan ^b   Hultgren, Olof ^b   Hultgren Hörnquist, Elisabeth ^a  

^a ÖREBRO UNIVERSITY   (Sweden)

^b ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Collagenous colitis; Interleukin 37; Lymphocytic colitis; MicroRNA; Ulcerative colitis

Indexed keywords

INTERLEUKI 37; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 3; MICRORNA; MICRORNA 146A; MICRORNA 155; MICRORNA 21; RNA; TOLL LIKE RECEPTOR; UNCLASSIFIED DRUG; AUTACOID; IL37 PROTEIN, HUMAN; IRAK3 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COLLAGENOUS COLITIS; COLON BIOPSY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPHOCYTIC COLITIS; MALE; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REMISSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; SIGNAL TRANSDUCTION; STATISTICAL SIGNIFICANCE; ULCERATIVE COLITIS; VERY ELDERLY; BIOPSY; CASE CONTROL STUDY; COLITIS, COLLAGENOUS; COLITIS, LYMPHOCYTIC; COLITIS, ULCERATIVE; COLON; COMPARATIVE STUDY; GENETICS; IMMUNOLOGY; INTESTINE MUCOSA; METABOLISM; MIDDLE AGED; PATHOLOGY;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY; CASE-CONTROL STUDIES; COLITIS, COLLAGENOUS; COLITIS, LYMPHOCYTIC; COLITIS, ULCERATIVE; COLON; FEMALE; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-1; INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASES; INTESTINAL MUCOSA; MALE; MICRORNAS; MIDDLE AGED; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS;

EID: 84909606787     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i34.12249     Document Type: Article

References (39)

1. Tysk C, Wickbom A, Nyhlin N, Eriksson S, Bohr J. Recent advances in diagnosis and treatment of microscopic colitis. Ann Gastroenterol 2011; 24: 253-262 [PMID: 24713787]
2. Pardi DS, Kelly CP. Microscopic colitis. Gastroenterology 2011; 140: 1155-1165 [PMID: 21303675 DOI: 10.1053/j.gastro.2011.02.003]
3. Münch A, Aust D, Bohr J, Bonderup O, Fernández Bañares F, Hjortswang H, Madisch A, Munck LK, Ström M, Tysk C, Miehlke S. Microscopic colitis: Current status, present and future challenges: statements of the European Microscopic Colitis Group. J Crohns Colitis 2012; 6: 932-945 [PMID: 22704658 DOI: 10.1016/j.crohns.2012.05.014]
4. Mahajan D, Goldblum JR, Xiao SY, Shen B, Liu X. Lymphocytic colitis and collagenous colitis: a review of clinicopathologic features and immunologic abnormalities. Adv Anat Pathol 2012; 19: 28-38 [PMID: 22156832 DOI: 10.1097/PAP.0b013e31823d7705]
5. Warren BF, Edwards CM, Travis SP. 'Microscopic colitis': classification and terminology. Histopathology 2002; 40: 374-376 [PMID: 11943023 DOI: 10.1046/j.1365-2559.2002.01341.x]
6. Kumar H, Kawai T, Akira S. Pathogen recognition by the innate immune system. Int Rev Immunol 2011; 30: 16-34 [PMID: 21235323 DOI: 10.3109/08830185.2010.529976]
7. Drexler SK, Foxwell BM. The role of toll-like receptors in chronic inflammation. Int J Biochem Cell Biol 2010; 42: 506-518 [PMID: 19837184 DOI: 10.1016/j.biocel.2009.10.009]
8. Kawagoe T, Sato S, Matsushita K, Kato H, Matsui K, Kumagai Y, Saitoh T, Kawai T, Takeuchi O, Akira S. Sequential control of Toll-like receptor-dependent responses by IRAK1 and IRAK2. Nat Immunol 2008; 9: 684-691 [PMID: 18438411 DOI: 10.1038/ni.1606]
9. Oshima N, Ishihara S, Rumi MA, Aziz MM, Mishima Y, Kadota C, Moriyama I, Ishimura N, Amano Y, Kinoshita Y. A20 is an early responding negative regulator of Toll-like receptor 5 signalling in intestinal epithelial cells during inflammation. Clin Exp Immunol 2010; 159: 185-198 [PMID: 19912257 DOI: 10.1111/j.1365-2249.2009.04048.x]
10. Wesche H, Gao X, Li X, Kirschning CJ, Stark GR, Cao Z. IRAK-M is a novel member of the Pelle/interleukin-1 receptor-associated kinase (IRAK) family. J Biol Chem 1999; 274: 19403-19410 [PMID: 10383454 DOI: 10.1074/jbc.274.27.19403]
11. Balaci L, Spada MC, Olla N, Sole G, Loddo L, Anedda F, Naitza S, Zuncheddu MA, Maschio A, Altea D, Uda M, Pilia S, Sanna S, Masala M, Crisponi L, Fattori M, Devoto M, Doratiotto S, Rassu S, Mereu S, Giua E, Cadeddu NG, Atzeni R, Pelosi U, Corrias A, Perra R, Torrazza PL, Pirina P, Ginesu F, Marcias S, Schintu MG, Del Giacco GS, Manconi PE, Malerba G, Bisognin A, Trabetti E, Boner A, Pescollderungg L, Pignatti PF, Schlessinger D, Cao A, Pilia G. IRAK-M is involved in the pathogenesis of early-onset persistent asthma. Am J Hum Genet 2007; 80: 1103-1114 [PMID: 17503328 DOI: 10.1086/518259]
12. Kobayashi K, Hernandez LD, Galán JE, Janeway CA, Medzhitov R, Flavell RA. IRAK-M is a negative regulator of Toll-like receptor signaling. Cell 2002; 110: 191-202 [PMID: 12150927 DOI: 10.1016/S0092-8674(02)00827-9]
13. Berglund M, Melgar S, Kobayashi KS, Flavell RA, Hörnquist EH, Hultgren OH. IL-1 receptor-associated kinase M down-regulates DSS-induced colitis. Inflamm Bowel Dis 2010; 16: 1778-1786 [PMID: 20848470 DOI: 10.1002/ibd.21287]
14. Kumawat AK, Strid H, Tysk C, Bohr J, Hörnquist EH. Microscopic colitis patients demonstrate a mixed Th17/Tc17 and Th1/Tc1 mucosal cytokine profile. Mol Immunol 2013; 55: 355-364 [PMID: 23566938 DOI: 10.1016/j.molimm.2013.03.007]
15. O'Neill LA, Sheedy FJ, McCoy CE. MicroRNAs: the fine-tuners of Toll-like receptor signalling. Nat Rev Immunol 2011; 11: 163-175 [PMID: 21331081 DOI: 10.1038/nri2957]
16. O'Connell RM, Rao DS, Baltimore D. microRNA regulation of inflammatory responses. Annu Rev Immunol 2012; 30: 295-312 [PMID: 22224773 DOI: 10.1146/annurev-immunol-020711-075013]
17. Wu F, Zikusoka M, Trindade A, Dassopoulos T, Harris ML, Bayless TM, Brant SR, Chakravarti S, Kwon JH. MicroRNAs are differentially expressed in ulcerative colitis and alter expression of macrophage inflammatory peptide-2 alpha. Gastroenterology 2008; 135: 1624-1635.e24 [PMID: 18835392 DOI: 10.1053/j.gastro.2008.07.068]
18. Wu F, Zhang S, Dassopoulos T, Harris ML, Bayless TM, Meltzer SJ, Brant SR, Kwon JH. Identification of microRNAs associated with ileal and colonic Crohn's disease. Inflamm Bowel Dis 2010; 16: 1729-1738 [PMID: 20848482 DOI: 10.1002/ibd.21267]
19. Wu F, Guo NJ, Tian H, Marohn M, Gearhart S, Bayless TM, Brant SR, Kwon JH. Peripheral blood microRNAs distinguish active ulcerative colitis and Crohn's disease. Inflamm Bowel Dis 2011; 17: 241-250 [PMID: 20812331 DOI: 10.1002/ibd.21450]
20. Fasseu M, Tréton X, Guichard C, Pedruzzi E, Cazals-Hatem D, Richard C, Aparicio T, Daniel F, Soulé JC, Moreau R, Bouhnik Y, Laburthe M, Groyer A, Ogier-Denis E. Identification of restricted subsets of mature microRNA abnormally expressed in inactive colonic mucosa of patients with inflammatory bowel disease. PLoS One 2010; 5: [PMID: 20957151 DOI: 10.1371/journal.pone.0013160]
21. Takagi T, Naito Y, Mizushima K, Hirata I, Yagi N, Tomatsuri N, Ando T, Oyamada Y, Isozaki Y, Hongo H, Uchiyama K, Handa O, Kokura S, Ichikawa H, Yoshikawa T. Increased expression of microRNA in the inflamed colonic mucosa of patients with active ulcerative colitis. J Gastroenterol Hepatol 2010; 25 Suppl 1: S129-S133 [PMID: 20586854 DOI: 10.1111/j.1440-1746.2009.06216.x]
22. Bufler P, Gamboni-Robertson F, Azam T, Kim SH, Dinarello CA. Interleukin-1 homologues IL-1F7b and IL-18 contain functional mRNA instability elements within the coding region responsive to lipopolysaccharide. Biochem J 2004; 381: 503-510 [PMID: 15046617 DOI: 10.1042/BJ20040217]
23. Nold MF, Nold-Petry CA, Zepp JA, Palmer BE, Bufler P, Dinarello CA. IL-37 is a fundamental inhibitor of innate immunity. Nat Immunol 2010; 11: 1014-1022 [PMID: 20935647 DOI: 10.1038/ni.1944]
24. Boraschi D, Lucchesi D, Hainzl S, Leitner M, Maier E, Mangelberger D, Oostingh GJ, Pfaller T, Pixner C, Posselt G, Italiani P, Nold MF, Nold-Petry CA, Bufler P, Dinarello CA. IL-37: a new anti-inflammatory cytokine of the IL-1 family. Eur Cytokine Netw 2011; 22: 127-147 [PMID: 22047735 DOI: 10.1684/ecn.2011.0288]
25. Imaeda H, Takahashi K, Fujimoto T, Kasumi E, Ban H, Bamba S, Sonoda H, Shimizu T, Fujiyama Y, Andoh A. Epithelial expression of interleukin-37b in inflammatory bowel disease. Clin Exp Immunol 2013; 172: 410-416 [PMID: 23600829 DOI: 10.1111/cei.12061]
26. Kumawat AK, Strid H, Elgbratt K, Tysk C, Bohr J, Hultgren Hörnquist E. Microscopic colitis patients have increased proportions of Ki67(+) proliferating and CD45RO(+) active/memory CD8(+) and CD4(+)8(+) mucosal T cells. J Crohns Colitis 2013; 7: 694-705 [PMID: 22995775 DOI: 10.1016/j.crohns.2012.08.014]
27. Dignass A, Eliakim R, Magro F, Maaser C, Chowers Y, Geboes K, Mantzaris G, Reinisch W, Colombel JF, Vermeire S, Travis S, Lindsay JO, Van Assche G. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 1: definitions and diagnosis. J Crohns Colitis 2012; 6: 965-990 [PMID: 23040452 DOI: 10.1016/j.crohns.2012.09.003]
28. Schroeder KW, Tremaine WJ, Ilstrup DM. Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. N Engl J Med 1987; 317: 1625-1629 [PMID: 3317057 DOI: 10.1056/NEJM198712243172603]
29. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001; 25: 402-408 [PMID: 11846609 DOI: 10.1006/meth.2001.1262]
30. Sheedy FJ, Palsson-McDermott E, Hennessy EJ, Martin C, O'Leary JJ, Ruan Q, Johnson DS, Chen Y, O'Neill LA. Negative regulation of TLR4 via targeting of the proinflammatory tumor suppressor PDCD4 by the microRNA miR-21. Nat Immunol 2010; 11: 141-147 [PMID: 19946272 DOI: 10.1038/ni.1828]
31. Keating SE, Maloney GM, Moran EM, Bowie AG. IRAK-2 participates in multiple toll-like receptor signaling pathways to NFkappaB via activation of TRAF6 ubiquitination. J Biol Chem 2007; 282: 33435-33443 [PMID: 17878161 DOI: 10.1074/jbc.M705266200]
32. Weersma RK, Oostenbrug LE, Nolte IM, Van Der Steege G, Oosterom E, Van Dullemen HM, Kleibeuker JH, Dijkstra G. Association of interleukin-1 receptor-associated kinase M (IRAK-M) and inflammatory bowel diseases. Scand J Gastroenterol 2007; 42: 827-833 [PMID: 17558906 DOI: 10.1080/00365520601114024]
33. Taganov KD, Boldin MP, Chang KJ, Baltimore D. NFkappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci USA 2006; 103: 12481-12486 [PMID: 16885212 DOI: 10.1073/pnas.0605298103]
34. Gitter AH, Wullstein F, Fromm M, Schulzke JD. Epithelial barrier defects in ulcerative colitis: characterization and quantification by electrophysiological imaging. Gastroenterology 2001; 121: 1320-1328 [PMID: 11729111 DOI: 10.1053/gast.2001.29694]
35. Wang P, Hou J, Lin L, Wang C, Liu X, Li D, Ma F, Wang Z, Cao X. Inducible microRNA-155 feedback promotes type I IFN signaling in antiviral innate immunity by targeting suppressor of cytokine signaling 1. J Immunol 2010; 185: 6226-6233 [PMID: 20937844 DOI: 10.4049/jimmunol.1000491]
36. O'Connell RM, Chaudhuri AA, Rao DS, Baltimore D. Inositol phosphatase SHIP1 is a primary target of miR-155. Proc Natl Acad Sci USA 2009; 106: 7113-7118 [PMID: 19359473 DOI: 10.1073/pnas.0902636106]
37. Rodriguez A, Vigorito E, Clare S, Warren MV, Couttet P, Soond DR, van Dongen S, Grocock RJ, Das PP, Miska EA, Vetrie D, Okkenhaug K, Enright AJ, Dougan G, Turner M, Bradley A. Requirement of bic/microRNA-155 for normal immune function. Science 2007; 316: 608-611 [PMID: 17463290 DOI: 10.1126/science.1139253]
38. McNamee EN, Masterson JC, Jedlicka P, McManus M, Grenz A, Collins CB, Nold MF, Nold-Petry C, Bufler P, Dinarello CA, Rivera-Nieves J. Interleukin 37 expression protects mice from colitis. Proc Natl Acad Sci USA 2011; 108: 16711-16716 [PMID: 21873195 DOI: 10.1073/pnas.1111982108]
39. Rasmussen MA, Munck LK. Systematic review: are lymphocytic colitis and collagenous colitis two subtypes of the same disease - microscopic colitis? Aliment Pharmacol Ther 2012; 36: 79-90 [PMID: 22670660 DOI: 10.1111/j.1365-2036.2012.05166.x]